Floatz logo

FLURBIPROFEN

Arthritis

Express Specialty PharmacySmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

2 Active assets in the Arthritis cohort.

Asset / SponsorPhaseRating
DICLOFENAC
Express Specialty Pharmacy
Phase 4BBB
PROPOFOL
Pedro Paulo Tanaka
Phase 4BB
Desflurane
Pedro Paulo Tanaka
Phase 4BB
TESTOSTERONE UNDECYLATE
Alliance for Clinical Trials in Oncology
Phase 3BB
Letrozole
ARKAY Therapeutics
Phase 2BB

View all 33 →

Same molecule, other indications

FLURBIPROFEN is also rated in:

Healthy Adult ParticipantsDormant
CC
Indicative ·
47 / 100
View asset →
Leukemia, Myeloid, AcuteDormant
CC
Indicative ·
44 / 100
View asset →
sickle cell diseaseDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →